United States Department of Defense
1400 Defense Pentagon, Room 1E757
Washington
D.C.
20301-1400
Tel: 703-697-5737
Website: http://www.defenselink.mil/
29 articles with United States Department of Defense
-
Ellume Announces $231.8 Million Agreement with the U.S. Government to Scale Up Production of COVID-19 Home Tests
2/1/2021
The investment will support the establishment of Ellume’s first U.S. manufacturing facility, increasing Ellume’s global production capacity by 500,000+ tests per day once completed
-
Just - Evotec Biologics Expands Contract with the Department of Defense for Manufacturing of Monoclonal Antibodies
1/27/2021
Evotec SE announced that the U.S. Department of Defense awarded its Seattle, Washington-based subsidiary, Just - Evotec Biologics, Inc., an agreement worth $28.6 million for the production of monoclonal antibodies for use in the development of a treatment and/or prophylaxis for COVID-19.
-
Humanetics Corporation Receives Funding From Department of Defense to Test Drug Against COVID-19
1/26/2021
BIO 300 will be tested as a post-infection prophylactic to mitigate pulmonary inflammation leading to COVID-19 complications
-
Cue's Molecular, Point-of-Care COVID-19 Tests Now Available in 10 States Under Health and Human Services and Department of Defense Pilot Program
1/19/2021
Cue Health Inc. announced that its molecular, point-of-care COVID-19 Tests are being distributed to five additional states, including Colorado, Minnesota, Pennsylvania, Rhode Island and Utah, as part of the joint $481 million program with the U.S. Department of Health and Human Services and the Department of Defense.
-
The U.S. Department of Defense awarded Moderna a contract worth $1,966,598,000 for an additional 100 million doses of its COVID-19 vaccine.
-
BioXcel Therapeutics Announces Grant by U.S. Department of Defense to Evaluate BXCL501 in Patients Suffering from PTSD
12/7/2020
Grant will support clinical studies in patients with post-traumatic stress disorder related to alcohol and substance abuse
-
Humanigen Announces Cooperative Research and Development Agreement with the Department of Defense to Develop Lenzilumab for COVID-19
11/6/2020
The Cooperative Research and Development Agreement (CRADA) with the Department of Defense (DoD) in support of Operation Warp Speed (OWS) aims to improve the availability of lenzilumab for patients with COVID-19 Humanigen’s development efforts complemented by full-scale, integrated team of OWS leading experts and U.S. Government decision makers dedicated to advancing lenzilumab ahead of a potential Emergency Use Authorization (EUA) submission
-
Department of Defense Awards Ology Bioservices Contract to Manufacture and Test Novel Live Attenuated Tularemia Vaccine Candidate
10/27/2020
Ology Bioservices Inc. (Ology Bio), a biologics contract development and manufacturing organization (CDMO), announced today that the Department of Defense (DOD), through the Joint Science and Technology Office of the Defense Threat Reduction Agency (DTRA), has awarded the company with a contract to manufacture a novel live attenuated tularemia vaccine. The contract value is $6.3 million. The vaccine candidate ATI-1701
-
Partner Therapeutics Announces $35 Million Contract with U.S. Department of Defense for Advanced Development and Emergency Use of Leukine® (rhuGM-CSF) for COVID-19 Acute Hypoxemic Respiratory Failure (AHRF)
8/4/2020
Funding will support two randomized, multi-center clinical trials in COVID-19 patients, expansion of manufacturing capacity and potential Emergency Use Authorization filing
-
DOD to Fund a Multi-Center Randomized Clinical Trial of COVID-19 Treatment With ExThera’s Seraph 100 Blood Filter
6/9/2020
After encouraging preliminary results in the treatment of critically-ill COVID-19 patients at a military hospital in the United States and fourteen other hospitals in Europe, the Department of Defense has selected the Seraph®100 Microbind® Affinity Blood Filter (Seraph 100) as one of its main interventions in a pivotal, US-based randomized controlled trial. Financial support for the multi-center trial will be provided
-
“We are genuinely honored at the opportunity to protect our military personnel and their families who have devoted themselves to the needs of U.S. citizens and others worldwide,” said Stanley C. Erck, president and chief executive officer of Novavax.
-
US Department of Defense Selects XENDEE for Standardized Design Platform of Resilient Microgrids
5/26/2020
XENDEE Corporation has signed a contract with the US Department of Defense (DoD) to develop the Standardized Platform to Guide Rapid and Repeatable Modelling and Design of Secure and Resilient DoD Microgrids globally. XENDEE has been tasked to deliver design solutions that enhance energy reliability, while providing new services such as the ability to safely ride-out prolonged utility power outages and sustain mission critica
-
physIQ, Department of Defense, and The Henry M. Jackson Foundation for The Advancement of Military Medicine Partner to Deploy Continuous Remote Monitoring Platform to Study COVID-19
5/7/2020
This DOD-funded initiative will assess the role of home-based continuous biosensor data and AI analytics in addressing the global COVID-19 crisis.
-
3M Awarded Department of Defense Contracts to Further Expand U.S. Production of N95 Respirators
5/7/2020
Company will increase U.S. production from 35 million per month to more than 95 million per month by October.
-
MRIGlobal To Deliver Three Mobile Medical Labs For Department Of Defense
5/5/2020
MRIGlobal's Athena, state-of-the-art, next generation mobile laboratories will augment U.S. Army's ability to rapidly test for COVID-19
-
NCMS Announces Partnership With DOD And FEMA For Medical Supplies
4/2/2020
The National Center for Manufacturing Sciences (NCMS) is pleased to announce a new partnership with the Department of Defense (DOD) and the Federal Emergency Management Agency (FEMA) to support the critical shortage of medical equipment and supplies. Tapping into our significant network of American manufacturers, and working al
-
With Superbugs and Antibiotic Resistance on the Rise, VA Facilities Make Infection Prevention a Priority
9/10/2019
Geo-Med & Xenex Enhance Veteran Safety with Infection Prevention Programs Utilizing LightStrike Germ-Zapping Robots
-
Hill-Rom Devices Earn U.S. Department of Defense Authority to Operate
4/23/2019
Vital Signs Monitoring Systems and Cardiology Technology Meet Stringent Data Security Standards
-
Hemopure® to be evaluated in groundbreaking clinical study of trauma patients in the prehospital setting, sponsored by the United States Department of Defense, and coordinated by Stellenbosch University
11/8/2018
Patient enrollment expected to commence in mid 2019
-
As we end October and head into November, the Food and Drug Administration (FDA) continues its work. This upcoming week has several PDUFA action dates for drug applications. Here’s a look.